Cardinal Health, Inc. $CAH Shares Sold by Sumitomo Mitsui Trust Group Inc.

Posted by on Jul 11th, 2026

Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.7% during the first quarter, HoldingsChannel.com reports. The firm owned 569,204 shares of the company’s stock after selling 34,350 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Cardinal Health were worth $120,278,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in CAH. Vanguard Group Inc. grew its position in Cardinal Health by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after acquiring an additional 617,775 shares during the period. State Street Corp raised its holdings in shares of Cardinal Health by 1.8% in the 4th quarter. State Street Corp now owns 12,509,230 shares of the company’s stock worth $2,570,647,000 after purchasing an additional 221,497 shares during the period. Geode Capital Management LLC lifted its stake in shares of Cardinal Health by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after purchasing an additional 43,924 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Cardinal Health during the 4th quarter worth about $790,344,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of CAH stock traded up $1.77 during mid-day trading on Friday, reaching $235.54. 2,842,646 shares of the company were exchanged, compared to its average volume of 2,287,700. The business’s 50 day simple moving average is $212.35 and its 200 day simple moving average is $212.99. The company has a market capitalization of $55.16 billion, a P/E ratio of 36.01, a P/E/G ratio of 1.15 and a beta of 0.49. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $243.21.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the prior year, the company posted $2.35 earnings per share. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.50%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CAH. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. Zacks Research lowered shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Wells Fargo & Company decreased their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Robert W. Baird set a $248.00 price target on Cardinal Health in a report on Friday, May 1st. Finally, Bank of America raised their price objective on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $249.13.

Read Our Latest Stock Analysis on CAH

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.